loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 200677 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 PASIREOTIDE DIASPARTATE (3)

filter

01 RECORDATI RARE (3)

filter

01 SOLUTION;SUBCUTANEOUS (3)

filter

01 EQ 0.3MG BASE/ML (EQ 0.3MG BASE/ML) (1)

02 EQ 0.6MG BASE/ML (EQ 0.6MG BASE/ML) (1)

03 EQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML) (1)

filter

01 USA (3)

URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
EQ 0.3MG BASE/ML (EQ 0...
SIGNIFOR
USA
200677
2012-12-14
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
EQ 0.6MG BASE/ML (EQ 0...
SIGNIFOR
USA
200677
2012-12-14
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
EQ 0.9MG BASE/ML (EQ 0...
SIGNIFOR
USA
200677
2012-12-14
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 200677

Looking for CTD TGA MCC DOSSIER APPLICATION 200677 3

19

Recordati, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is PASIREOTIDE DIASPARTATE, with a corresponding application number 200677 and regulatory information .

proudly manufactured in the

approval since 2012-12-14

Recordati's SIGNIFOR SOLUTION;SUBCUTANEOUS, medication with EQ 0.3MG BASE/ML (EQ 0.3MG BASE/ML) of PASIREOTIDE DIASPARTATE.

18

Recordati, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is PASIREOTIDE DIASPARTATE, with a corresponding application number 200677 and regulatory information .

proudly manufactured in the

approval since 2012-12-14

Recordati's SIGNIFOR SOLUTION;SUBCUTANEOUS, medication with EQ 0.6MG BASE/ML (EQ 0.6MG BASE/ML) of PASIREOTIDE DIASPARTATE.

17

Recordati, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is PASIREOTIDE DIASPARTATE, with a corresponding application number 200677 and regulatory information .

proudly manufactured in the

approval since 2012-12-14

Recordati's SIGNIFOR SOLUTION;SUBCUTANEOUS, medication with EQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML) of PASIREOTIDE DIASPARTATE.

Post Enquiry
POST ENQUIRY